Robert Martin Emanuele, Senior VP, Development at ADVENTRX PHARMACEUTICALS INC (ANX), sold 41,000 shares at $0.60 ($25K) on 2011-12-16, disclosed to the SEC on 2011-12-19.
Scheduled sale ($25k) by Senior VP, Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.